Related Experiment Videos
Chronic hepatitis. The challenge of diagnosis and treatment
1Department of Medicine, St. Vincent's Medical Center of Richmond, Staten Island, NY 10310.
Insights
Chronic hepatitis diagnosis requires distinguishing between persistent and active forms, often needing a liver biopsy. Treatment varies, with chronic active hepatitis responding to diverse therapies like corticosteroids and antivirals.
Area of Science:
- Hepatology
- Internal Medicine
- Gastroenterology
Background:
- Chronic hepatitis has diverse causes, including viruses and medications.
- In approximately 80% of cases, the etiology of chronic hepatitis remains unidentified.
- Differentiating chronic persistent hepatitis from chronic active hepatitis is crucial for patient management.
Purpose of the Study:
- To highlight the diagnostic importance of differentiating chronic persistent hepatitis from chronic active hepatitis.
- To outline the therapeutic approaches for chronic active hepatitis.
- To discuss the prognostic factors influencing outcomes in chronic hepatitis.
Main Methods:
- Percutaneous liver biopsy is the gold standard for distinguishing between chronic persistent and chronic active hepatitis.
- Review of current therapeutic options for chronic active hepatitis.
- Analysis of factors affecting prognosis in chronic hepatitis.
Main Results:
- Chronic persistent hepatitis generally does not require specific treatment.
- Chronic active hepatitis demonstrates responsiveness to a broad spectrum of treatments, including corticosteroids, immunosuppressants, antivirals, and immunostimulants.
- Prognosis is contingent upon treatment efficacy, potential risks, disease severity, and underlying cause.
Conclusions:
- Accurate diagnosis through liver biopsy is essential for appropriate hepatitis management.
- Chronic active hepatitis necessitates therapeutic intervention, with multiple treatment modalities available.
- Prognosis is multifactorial, influenced by disease characteristics and therapeutic decisions.
Abstract:
Chronic hepatitis can be caused by a variety of viruses or therapeutic agents, but in about 80% of cases, the cause is unknown. Distinguishing between chronic persistent and chronic active hepatitis is of primary importance in diagnosis and treatment. Percutaneous liver biopsy is necessary to make the distinction. In most cases, chronic persistent hepatitis does not necessitate specific therapy. Chronic active hepatitis responds to a wide range of therapeutic options: corticosteroids, immunosuppressants, antivirals, and immunostimulants. Prognosis depends on the risks and advantages of therapy as well as the severity and cause of the disease.